Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:07:56.015Z.
Consensus retrieved: 2026-10-06T12:18:50.608Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:07:56.015Z.
Quote observation: 2026-10-06T16:03:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eab42942c27d7457dfc33c45bb783e1a271ca5ab59202131f9efdd6250b8ad0
Forward PE Ratio (N/A) = Dated Quote Price ($0.57) / Consensus Forward EPS ($-10.23)
FORWARD PE RATIO
N/A
Healthcare Triangle, Inc.
Market Cap
$8.52M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.52M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.23M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.11M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.03M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.10M | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.93M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.34M | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.64M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.57, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-10.23 | $-10.23 – $-10.23 | 1 | n/m |
| 2027-12-31 | $-3.18 | $-3.18 – $-3.18 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
